Wouter J. C. van Ballegoij

International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy

Marc Engelen, Wouter J. C. van Ballegoij, Eric J. Mallack et al. · Neurology · 2022 · 141 citations · Full text

Medicine, Endocrinology, Medical Genetics +3

Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness

Irene C. Huffnagel, Wouter J. C. van Ballegoij, Björn M. van Geel et al. · Brain · 2018 · 65 citations · Full text

Medicine, Neurology, Movement Disorders +10

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler et al. · The Lancet Neurology · 2023 · 42 citations · Full text

Medicine, Endocrinology, Pharmacology +4

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Wouter J. C. van Ballegoij, Stephanie I. W. van de Stadt, Irene C. Huffnagel et al. · Annals of Clinical and Translational Neurology · 2020 · 36 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy

Irene C. Huffnagel, Wouter J. C. van Ballegoij, Johanna M B W Vos et al. · Neurology · 2019 · 22 citations · Full text

Medicine, Neurology, Neuroscience +17